Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Reduction in Covid-19 Vaccine Effectiveness against Sars-CoV-2 Variants in Seoul according to Age, Sex, and Symptoms

A Test-Negative Case-Control Study

Bibliographic Data

ID15512702
AuthorsHyerin Gim (0000-0001-9755-3389, Seoul Metropolitan Government), So-Young Oh (0000-0001-7750-6518, Seoul Metropolitan Government), Heeda Lee (Seoul Metropolitan Government), Seul Lee (0009-0001-7966-8200, Seoul Metropolitan Government), Haesook Seo (0000-0002-3554-6172, Seoul Metropolitan Government), Yumi Park (0009-0006-6537-2333, Seoul Metropolitan Government, corresponding author), Jae‐Hyun Park (0000-0001-5860-7487, Sungkyunkwan University, corresponding author), Jae-Hyun Park (0000-0002-8029-7312, Department of Social and Preventive Medicine, Sungkyunkwan University School of Medicine, 2066 Seobu-ro, Jangan-gu, Suwon 16419, Republic of Korea)
Year2022
Volume19
Issue24
Pages16958-16958
Publication date2022-12-16
Peer ReviewedYes
Open AccessYes
TypeARTICLE
VenueInternational Journal of Environmental Research and Public Health (JOURNAL)
Journal identifiersISSN: 1661-7827 • E-ISSN: 1660-4601
PublisherMultidisciplinary Digital Publishing Institute (PUBLISHER • CH)
DOI10.3390/ijerph192416958
PMID36554839
OpenAlexW4312195454
LanguageEN
Citations received1
References cited41

Vaccine-mediated protection drastically declined during the delta-dominant period and in vulnerable groups. This study suggests the requirement for additional countermeasures, such as the administration of a booster vaccine, in vulnerable groups based on age, sex, and symptomatic manifestation

Asymptomatic · Confidence interval · Confounding · Coronavirus disease 2019 (COVID-19 · Disease · Environmental health · Incidence (geometry · Infectious disease (medical specialty · Population · COVID-19 Clinical Research Studies · Demography · Medicine · SARS-CoV-2 and COVID-19 Research · Vaccine Coverage and Hesitancy · Internal Medicine

  • Estimation of Total Cost Required in Controlling Covid-19 Outbreaks by Financial Incentives

    Open Access•Sangkwon Kim, Youngjin Hwang et al.•International Journal of…•2023

  • Impact and effectiveness of mRNA BNT162b2 vaccine against Sars-CoV-2 infections and Covid-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel

    Open Access•Eric J Haas, Frederick J Angulo et al.•The Lancet•2021

  • Sex differences in immune responses

    Open Access•Sabra L Klein, Katie L Flanagan•Nature Reviews Immunology•2016

  • Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

    Open Access•Fernando P Polack, Stephen J Thomas et al.•New England Journal of Medicine•2020

  • BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting

    Open Access•Noa Dagan, Noam Barda et al.•New England Journal of Medicine•2021

  • Epidemiological investigation on hand hygiene knowledge and behaviour

    Open Access•Lorna Kwai Ping Suen, Zoe Y Y So et al.•BMC Public Health•2019

Unique citing works1
Citations per year0,33
Citation span2023 - 2023 (1)
Citation velocityhistorical
Highly citedNo
Citation typesNeutral: 1

Tools

Open DOIOpen Access
Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae